Yahoo
Paris - Delayed Quote EUR

ABIVAX Société Anonyme (ABVX.PA)

77.15 -0.50 (-0.64%)
At close: November 6 at 5:36:06 PM GMT+1

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
Name Title Pay Exercised Year Born
Mr. Marc M. P. de Garidel M.B.A.
CEO & Director 1.15M -- 1958
Mr. Didier Blondel
EVP, CFO & Board Secretary -- -- 1964
Mr. Timothy P. Kelly M.B.A.
Chief Technical Officer -- -- 1969
Mr. Patrick Malloy
Senior VP & Head of Investor Relations -- -- --
Ms. Ida Hatoum
Chief People & Compliance Officer -- -- 1975
Mr. James Berger
Global Head of Marketing -- -- --
Mr. Pierre Courteille M.B.A.
Chief Business Officer -- -- 1969
Hema Keshava
Senior Vice President of Finance -- -- --
Mr. Chris Rabbat Ph.D.
Chief Medical Officer -- -- --
Kevin Shan Ph.D.
VP & Global Head of Biometrics -- -- --

ABIVAX Société Anonyme

7-11 Boulevard Haussmann
Paris, 75009
France
33 1 53 83 09 63 https://www.abivax.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
98

Description

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Corporate Governance

ABIVAX Société Anonyme’s ISS Governance QualityScore as of November 1, 2026 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 6; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

September 21, 2026 at 3:30 PM UTC

ABIVAX Société Anonyme Earnings Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: